BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 13993069)

  • 1. Hypotensive action methyldopa.
    SMIRK H
    Br Med J; 1963 Jan; 1(5324):146-51. PubMed ID: 13993069
    [No Abstract]   [Full Text] [Related]  

  • 2. [alpha-Methyl-dopa, new drug with hypotensive action].
    PESSINA G
    Boll Chim Farm; 1962 Sep; 101():731-4. PubMed ID: 13942674
    [No Abstract]   [Full Text] [Related]  

  • 3. [CLINICAL TRIAL OF A HYPOTENSIVE DRUG: 3,4-DIHYDROXY-D-L-PHENYLALANINE OR METHYLDOPA].
    MILLIEZ P; FRITEL D; REY LP
    Presse Med (1893); 1964 Oct; 72():2519-20. PubMed ID: 14191627
    [No Abstract]   [Full Text] [Related]  

  • 4. [NEW HYPOTENSIVE DRUGS].
    DALMAU-CIRIA M
    Med Clin (Barc); 1964 Mar; 42():225-6. PubMed ID: 14170785
    [No Abstract]   [Full Text] [Related]  

  • 5. [New hypotensive medications: guanethidine, alphamethyldopa, mecamylamine].
    BADOUAL J
    Vie Med; 1963 Mar; 44():83-8. PubMed ID: 13966042
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolonged profound hypotension complicating severe methyldopa overdose.
    Chan TY; Joynt GM
    Int J Clin Pharmacol Ther; 2014 Jul; 52(7):628-30. PubMed ID: 24755131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [PRELIMINARY OBSERVATIONS ON A NEW HYPOTENSIVE AGENT: METHYLDOPA].
    DE MENEZES JG; AMENDOLA O; LEMLE A; BERG R
    Rev Bras Med; 1963 Jun; 20():334-40. PubMed ID: 14160822
    [No Abstract]   [Full Text] [Related]  

  • 8. Another hypotensive agent--methyldopa.
    DALEY D; EVANS B
    Br Med J; 1962 Jul; 2(5298):156-8. PubMed ID: 13883201
    [No Abstract]   [Full Text] [Related]  

  • 9. TREATMENT OF HYPERTENSION. AN EVALUATION OF ALPHA-METHYLDOPA.
    PILLSBURY PL; CHRISTENSEN JA
    Calif Med; 1963 Sep; 99(3):176-7. PubMed ID: 14047630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [SEVERE NEUROLOGICAL SIDE-EFFECTS IN HYPOTENSION THERAPY].
    BOETTIGER LE; MALMBORG RO; MICHAELI EW
    Nord Med; 1964 Apr; 71():523-5. PubMed ID: 14131560
    [No Abstract]   [Full Text] [Related]  

  • 11. Overdose of methyldopa, indapamide and theophylline resulting in prolonged hypotension, marked diuresis and hypokalaemia in an elderly patient.
    Chan TY; Gomersall CD; Cheng CA; Woo J
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):977-9. PubMed ID: 19623566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyrotropin releasing hormone and naloxone attenuate the antihypertensive action of central alpha 2-adrenoceptor stimulation through different mechanisms.
    Kunos G; Newman F; Farsang C; Ungar W
    Endocrinology; 1984 Dec; 115(6):2481-3. PubMed ID: 6094160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial of a new hypotensive drug, methyldopa ("aldomet").
    BAUMGARTEN A
    Med J Aust; 1962 Jul; 49(2)():52-5. PubMed ID: 13865946
    [No Abstract]   [Full Text] [Related]  

  • 14. [CLINICAL EXPERIENCE WITH A NEW HYPOTENSIVE DRUG: ALPHA-METHYL-DOPA].
    SERVI M; CANTERA N
    Clin Ter; 1963 Jul; 26():158-69. PubMed ID: 14050042
    [No Abstract]   [Full Text] [Related]  

  • 15. Antagonism by naltrexone of the hypotension and bradycardia induced by alpha-methyldopa in conscious normotensive rats.
    van Giersbergen PL; de Jong W
    J Pharmacol Exp Ther; 1988 Jan; 244(1):341-7. PubMed ID: 2961881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RECENT ADVANCES AND TRENDS IN DRUG THERAPY. 3. HYPOTENSIVE AGENTS.
    ROWE WS
    Med J Aust; 1964 Nov; 2():804-6. PubMed ID: 14221991
    [No Abstract]   [Full Text] [Related]  

  • 17. [A new-type hypotensive agent: alpha-methyl-DOPA].
    FRANCO A
    Actual Cardiol Angeiol Int (Paris); 1962; 11():303-6. PubMed ID: 13959170
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of orthostatic hypotension due to major hypotensive drugs (exception of ganglioplegics). Trial of dihydroergotamine].
    Conte J; Ader JL; Suc JM
    Nouv Presse Med; 1973 Jun; 2(26):1761-4. PubMed ID: 4724042
    [No Abstract]   [Full Text] [Related]  

  • 19. [Double-blind assay of a new hypotensive agent of central action, guanfacine, compared with alpha-methyldopa].
    Jiménez Casado M; Canto J; Yapur H; Oller JM
    Rev Clin Esp; 1984 Jul 15-31; 174(1-2):41-4. PubMed ID: 6393236
    [No Abstract]   [Full Text] [Related]  

  • 20. [ANTIHYPERTENSIVE ACTION OF A DOPA-DECARBOXYLASE INHIBITOR: METHYLDOPA].
    BENZI G
    Farmaco Prat; 1963 Dec; 18():688-93. PubMed ID: 14121022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.